Halogenation of N-substituted p-quinone monoimines and p-quinone monooxime ethers: XIV. Halogenation of N-[arylsulfonylimino(phenyl)methyl]-2,5-dialkyl-1,4-benzoquinone monoimines and their reduction products

Avdeenko, A. P.; Konovalova, S. A.; Ledeneva, O. P.; Santalova, A. A.; Пироженко, В. В.; Palamarchuk, G. V.; Шишкин, Олег В.

doi:10.1134/s107042801207007x

Cited by 2 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…17). Depending on the reaction conditions and substrate structure, the outcome is determined by the following processes: adding halogen, dehydrohalogenation, oxidation, reduction, hydrohalogenation, and electrophilic substitution (Avdeenko et al, 2012).…”

Section: Synthetic Methodsmentioning

confidence: 99%

Quinoid systems in chemistry and pharmacology

et al. 2015

View full text Add to dashboard Cite

In this paper, we present a brief review of quinoid systems, focusing on their chemical synthesis over the last decade. We address not only major methods of synthesizing quinoids, but also their involvement in biological processes. We highlight their medical relevance and versatility, including antitumor, antiretroviral, or antihypertensive agents, properties determined by their various patterns of substitution. Graphical AbstractKeywords Quinone Á Synthesis Á Cytotoxicity Á Natural products Á Pharmacology Á Redox Abbreviations 3a-HSD 3a-Hydroxysteroid dehydrogenase AIDS Acquired Immune Deficiency Syndrome AlnA Alnumycin A AlnB Alnumycin B BAQ Benzanthracene quinone (7,12-benzo[a] anthraquinone) BPQ Benzo[a]pyrene-7,8-dione CAN Ceric ammonium nitrate CC 50 50 % Cytotoxic concentration CDC25 Cell division cycle phosphatases Cyt Ferricytochrome d-A 2 0 -Deoxyadenosine DBU 1,8-Diazabicyclo[5.4.0]undec-7-ene DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone d-G, d-Guo 2'-Deoxyguanosine DMF N,N-dimethylformamide DMP Dess-Martin periodinane DMSO

show abstract

Section: Synthetic Methodsmentioning

confidence: 99%